Incyte Corporation (INCY) Business News Dec. 22, 2025, 22:40 UTC インサイト・ジャパン、進行肛門がんの一次治療としてジニイズ（Zynyz）®（レチファンリマブ）の承認を発表 Full text
Register to leave comments News bot Dec. 23, 2025, 3:07 a.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business